Artificial Neural Networks Analysis Used to Evaluate the Molecular Interactions between Selected Drugs and Human Cyclooxygenase2 Receptor
暂无分享,去创建一个
Mohammad Reza Saberi | Ali Baratian | M. N. naghibi sistani | M. Saberi | Ali Tayarani | Mohammad-Bagher Naghibi Sistani | Zeinab Tehranizadeh | A. Baratian | Z. Tehranizadeh | Ali Tayarani
[1] Fevzullah Temurtas,et al. A comparative study on diabetes disease diagnosis using neural networks , 2009, Expert Syst. Appl..
[2] A. Buciński,et al. Artificial neural networks analysis used to evaluate the molecular interactions between selected drugs and human alpha1-acid glycoprotein. , 2009, Journal of pharmaceutical and biomedical analysis.
[3] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[4] Mire Zloh,et al. Prediction of aqueous solubility of drug-like molecules using a novel algorithm for automatic adjustment of relative importance of descriptors implemented in counter-propagation artificial neural networks. , 2012, International journal of pharmaceutics.
[5] Xueguang Shao,et al. Protein-ligand recognition using spherical harmonic molecular surfaces: towards a fast and efficient filter for large virtual throughput screening. , 2002, Journal of molecular graphics & modelling.
[6] Shigeo Yamamura,et al. Clinical application of artificial neural network (ANN) modeling to predict pharmacokinetic parameters of severely ill patients. , 2003, Advanced drug delivery reviews.
[7] K. Asadpour‐Zeynali,et al. Modeling drug solubility in water-cosolvent mixtures using an artificial neural network. , 2004, Farmaco.
[8] Mohammad S. Iqbal,et al. A QSPR study of drug release from an arabinoxylan using ab initio optimization and neural networks , 2012 .
[9] Charles L. Brooks,et al. Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures , 2004, J. Comput. Chem..
[10] W. Richard Bowen,et al. DYNAMIC ULTRAFILTRATION OF PROTEINS-A NEURAL NETWORK APPROACH , 1998 .
[11] J. V. Turner,et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks. , 2004, International journal of pharmaceutics.
[12] J. Huuskonen,et al. Estimation of Aqueous Solubility for a Diverse Set of Organic Compounds Based on Molecular Topology. , 2010 .
[13] S. Agatonovic-Kustrin,et al. Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. , 2000, Journal of pharmaceutical and biomedical analysis.
[14] Brian B. Goldman,et al. QSD quadratic shape descriptors. 2. Molecular docking using quadratic shape descriptors (QSDock) , 2000, Proteins.
[15] Thomas Lengauer,et al. Computational methods for biomolecular docking. , 1996, Current opinion in structural biology.
[16] Jin Park,et al. A sequential neural network model for diabetes prediction , 2001, Artif. Intell. Medicine.
[17] Firat Hardalaç,et al. Classification of carotid artery stenosis of patients with diabetes by neural network and logistic regression , 2004, Comput. Biol. Medicine.
[18] GuanHua Chen,et al. A neural networks-based drug discovery approach and its application for designing aldose reductase inhibitors. , 2006, Journal of molecular graphics & modelling.
[19] Janet M. Thornton,et al. Real spherical harmonic expansion coefficients as 3D shape descriptors for protein binding pocket and ligand comparisons , 2005, Bioinform..